Stability studies of hot-melt extruded ternary solid dispersions of poorly-water soluble indomethacin with poly(vinyl pyrrolidone-co-vinyl acetate) and polyethylene oxide
暂无分享,去创建一个
[1] Noel M. Gately,et al. Investigation of miscibility estimation methods between indomethacin and poly(vinylpyrrolidone‐co‐vinyl acetate) , 2018, International journal of pharmaceutics.
[2] V. Zeleňák,et al. Ordered cubic nanoporous silica support MCM-48 for delivery of poorly soluble drug indomethacin , 2018, Applied Surface Science.
[3] R. Williams,et al. Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method. , 2018, Journal of pharmaceutical sciences.
[4] R. Suryanarayanan,et al. Use of a Plasticizer for Physical Stability Prediction of Amorphous Solid Dispersions , 2017 .
[5] J. Siepmann,et al. PEO hot melt extrudates for controlled drug delivery: Importance of the molecular weight , 2016 .
[6] G. Van den Mooter,et al. The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers , 2016, Expert opinion on drug delivery.
[7] G. Mooter,et al. The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers , 2016 .
[8] M. Hussain,et al. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction , 2016, Pharmaceutical Research.
[9] Bruno Sarmento,et al. Amorphous solid dispersions: Rational selection of a manufacturing process. , 2016, Advanced drug delivery reviews.
[10] F. Štěpánek,et al. Non-invasive insight into the release mechanisms of a poorly soluble drug from amorphous solid dispersions by confocal Raman microscopy. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[11] J. Aylott,et al. Indomethacin-Kollidon VA64 Extrudates: A Mechanistic Study of pH-Dependent Controlled Release. , 2016, Molecular pharmaceutics.
[12] M. Hussain,et al. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type. , 2016, Molecular pharmaceutics.
[13] R. Williams,et al. Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review , 2016, AAPS PharmSciTech.
[14] C. Strachan,et al. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage. , 2015, International journal of pharmaceutics.
[15] L. S. Taylor,et al. Phase separation kinetics in amorphous solid dispersions upon exposure to water. , 2015, Molecular pharmaceutics.
[16] S. Kazarian,et al. Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[17] Li Deng,et al. Applications of poly(ethylene oxide) in controlled release tablet systems: a review , 2014, Drug development and industrial pharmacy.
[18] Wei-guo Dai,et al. Fundamental aspects of solid dispersion technology for poorly soluble drugs , 2013, Acta pharmaceutica Sinica. B.
[19] T. Barder,et al. Correlation of Inhibitory Effects of Polymers on Indomethacin Precipitation in Solution and Amorphous Solid Crystallization Based on Molecular Interaction , 2013, Pharmaceutical Research.
[20] Q. Ping,et al. Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion , 2013 .
[21] G. Mooter,et al. The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. , 2012, Drug discovery today. Technologies.
[22] Li Di,et al. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery. , 2012, Molecular pharmaceutics.
[23] Feng Qian,et al. Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion? , 2010, International journal of pharmaceutics.
[24] R. Bodmeier,et al. Characterization and stability of solid dispersions based on PEG/polymer blends. , 2010, International journal of pharmaceutics.
[25] Peng Wang,et al. Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit E PO solid dispersions. , 2010, International journal of pharmaceutics.
[26] G. Van den Mooter,et al. Review: physical chemistry of solid dispersions , 2009 .
[27] A. Van Schepdael,et al. Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[28] R. Chokshi,et al. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. , 2008, Journal of pharmaceutical sciences.
[29] A. Van Schepdael,et al. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] R. Zelkó,et al. Tracking the physical aging of poly(ethylene oxide): A technical note , 2006, AAPS PharmSciTech.
[31] John G. Lyons,et al. Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process. , 2007, International journal of pharmaceutics.
[32] G. Van den Mooter,et al. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. , 2005, International journal of pharmaceutics.
[33] Geert Verreck,et al. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[34] Bruno C. Hancock,et al. What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.
[35] Charles E. Martin,et al. Pharmaceutical Extrusion Technology , 2003 .
[36] C Vervaet,et al. Characterization of ibuprofen as a nontraditional plasticizer of ethyl cellulose. , 2002, Journal of pharmaceutical sciences.
[37] D. Craig,et al. The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.
[38] G Zografi,et al. Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers. , 2001, Journal of pharmaceutical sciences.
[39] A. Serajuddin,et al. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.
[40] Bruno C. Hancock,et al. CHARACTERIZATION OF THE TIME SCALES OF MOLECULAR MOTION IN PHARMACEUTICALLY IMPORTANT GLASSES , 1999 .
[41] Nikolaos A. Peppas,et al. Crystal dissolution-controlled release systems: I. Physical characteristics and modeling analysis , 1997 .
[42] S. Bekiranov,et al. SOLUTION BEHAVIOR OF POLYETHYLENE OXIDE IN WATER AS A FUNCTION OF TEMPERATURE AND PRESSURE , 1997 .
[43] A Apicella,et al. Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release. , 1993, Biomaterials.
[44] L. Struik. The mechanical and physical ageing of semicrystalline polymers: 1 , 1987 .
[45] L. Struik. Mechanical behaviour and physical ageing of semi-crystalline polymers: 4 , 1987 .
[46] L. Rockland,et al. Saturated Salt Solutions for Static Control of Relative Humidity between 5° and 40° C. , 1960 .